Growth Metrics

Stemtech (STEK) Common Equity (2016 - 2025)

Stemtech's Common Equity history spans 6 years, with the latest figure at -$5.8 million for Q3 2025.

  • On a quarterly basis, Common Equity changed N/A to -$5.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.8 million, a N/A change, with the full-year FY2024 number at -$4.5 million, down 61.37% from a year prior.
  • Common Equity hit -$5.8 million in Q3 2025 for Stemtech, up from -$6.5 million in the prior quarter.
  • Over the last five years, Common Equity for STEK hit a ceiling of $896097.0 in Q1 2021 and a floor of -$28.8 million in Q2 2022.
  • Historically, Common Equity has averaged -$5.1 million across 5 years, with a median of -$4.4 million in 2021.
  • Biggest five-year swings in Common Equity: crashed 11505.16% in 2022 and later surged 87.17% in 2023.
  • Tracing STEK's Common Equity over 5 years: stood at -$4.0 million in 2021, then rose by 20.81% to -$3.2 million in 2022, then rose by 12.39% to -$2.8 million in 2023, then crashed by 61.37% to -$4.5 million in 2024, then fell by 29.35% to -$5.8 million in 2025.
  • Business Quant data shows Common Equity for STEK at -$5.8 million in Q3 2025, -$6.5 million in Q2 2025, and -$4.9 million in Q1 2025.